Vertex Pharmaceuticals Inc. (VRTX)

Index:

Nasdaq 100

$ 491.34
   
  • Change Today:
    $11.16
  • 52 Week High: $503.89
  • 52 Week Low: $374.46
  • Currency: US Dollars
  • Shares Issued: 235.99m
  • Volume: 8,693,047
  • Market Cap: $115,952m
  • RiskGrade: 164
  • Beta: 0.01

VRTX Overview

Vertex Pharmaceuticals Incorportated in a United States-based drug manufacturer. The company focuses on the research and development of small molecule drugs that are used in the treatment of diseases, including HIV infection & chronic hepatitis C virus.

Listings

Index: S&P 500, Nasdaq 100, Nasdaq Composite
ISIN: US92532F1003

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

VRTX Market Data

Currency US Dollars
Share Price $ 491.34
Change Today $ 11.16
% Change 2.32 %
52 Week High $503.89
52 Week Low $374.46
Volume 8,693,047
Shares Issued 235.99m
Market Cap $115,952m
Beta 0.01
RiskGrade 164

What The Brokers Say

Strong Buy 9
Buy 11
Neutral 8
Sell 1
Strong Sell 1
Total 30
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 26-Jun-2026

Time Volume / Share Price
15:59 40 @ $490.70
15:59 61 @ $490.85
15:59 40 @ $490.85
15:59 40 @ $491.09
15:59 97 @ $491.09

Top of Page